This category looked so sad and empty...
If the Phase three studies show that once daily oral orforglipron is at least as effective as injectable semaglutide, I can't help but think that it has the potential to explode and take over a huge percentage of the anti-obesity drug market. There is a...
glp1forum.com uses cookies and other similar functionality to help us personalize content, tailor your experience and to keep you logged in if you are a registered member.
By continuing to use this site, you are consenting to our use of cookies.